ADVANCED LEIOMYOSARCOMA
Clinical trials for ADVANCED LEIOMYOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED LEIOMYOSARCOMA trials appear
Sign up with your email to follow new studies for ADVANCED LEIOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Drug attack on Tough-to-Treat sarcoma
Disease control OngoingThis study is testing whether adding a newer drug, lurbinectedin, to a standard chemotherapy (doxorubicin) works better for treating advanced soft-tissue sarcoma. The first part checks the safety and best dose of the combination. The second part directly compares the new combinat…
Matched conditions: ADVANCED LEIOMYOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Lab-Grown Mini-Tumors used to pick best cancer drugs
Disease control ENROLLING_BY_INVITATIONThis study is testing a new, personalized way to choose the first treatment for advanced leiomyosarcoma, a type of cancer. Doctors will take a small sample of a patient's tumor and grow a miniature version of it in a lab. They will test different chemotherapy drugs on this 'organ…
Matched conditions: ADVANCED LEIOMYOSARCOMA
Phase: NA • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC